![]() |
|
|
Vol. 293, Issue 2, 426-434, May 2000
Molecular Neuropharmacology Section, Experimental Therapeutics
Branch, National Institute of Neurological Disorders and Stroke,
National Institutes of Health, Bethesda, Maryland
To investigate the role of the cAMP-dependent protein kinase (PKA) in
the desensitization and down-regulation of the D1 dopamine receptor, we stably expressed the rat cDNA for this receptor in mutant
Chinese hamster ovary (CHO) cell lines deficient in PKA activity. The
10260 mutant CHO cell line has been characterized as expressing less
than 10% of type I and type II PKA activities relative to the parental
10001 CHO cell line. The 10248 mutant CHO line lacks type II PKA
activity and expresses a defective type I PKA. The transfected parental
and mutant cell lines were found to express ~1 pmol/mg D1
receptor binding activity (Bmax) as
determined using [3H]SCH-23390 binding assays. All three
cell lines demonstrated similar levels of dopamine-stimulated adenylyl
cyclase activity. Pretreatment of all three CHO cells with dopamine
resulted in desensitization of the adenylyl cyclase response, although
the maximum desensitization was attenuated by 20 and 40% in the 10260 and 10248 cell lines, respectively. Dopamine also promoted, in a time-
and dose-dependent fashion, a >90% down-regulation of D1
receptors in the parental cell line but only a 50 and 30% decrease in
the 10260 and 10248 cells, respectively. Similarly, treatment of the
cells with the membrane-permeable cAMP analog
8-(4-chlorophenylthio)-cAMP induced functional desensitization and
down-regulation of the D1 receptor, although it was not as
great as that observed with agonist pretreatment. As with the agonist
pretreatments, the 8-(4-chlorophenylthio)-induced responses were
attenuated in the mutant cells with the 10248 line exhibiting the least
desensitization/down-regulation. Our results suggest that PKA
significantly contributes to the desensitization and down-regulation of
D1 receptors in CHO cells and that type II PKA may be the
more relevant isoform with respect to regulating D1
receptor function.
CNPq.
2
Present address: Departamento de Neurobiologia,
Universidade Federal Fluminense, Niteroi, Cx. Postal 100180-RJ,
24001-970 Brasil.
This article has been cited by other articles:
![]() |
J. Xu, Y. Chen, R. Lu, C. Cottingham, K. Jiao, and Q. Wang Protein Kinase A Phosphorylation of Spinophilin Modulates Its Interaction with the {alpha}2A-Adrenergic Receptor (AR) and Alters Temporal Properties of {alpha}2AAR Internalization J. Biol. Chem., May 23, 2008; 283(21): 14516 - 14523. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Banday, F. R. Fazili, and M. F. Lokhandwala Insulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C Am J Physiol Renal Physiol, September 1, 2007; 293(3): F877 - F884. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Beazely, J. K. Alan, and V. J. Watts Protein Kinase C and Epidermal Growth Factor Stimulation of Raf1 Potentiates Adenylyl Cyclase Type 6 Activation in Intact Cells Mol. Pharmacol., January 1, 2005; 67(1): 250 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
O.-J. Kim, B. R. Gardner, D. B. Williams, P. S. Marinec, D. M. Cabrera, J. D. Peters, C. C. Mak, K.-M. Kim, and D. R. Sibley The Role of Phosphorylation in D1 Dopamine Receptor Desensitization: EVIDENCE FOR A NOVEL MECHANISM OF ARRESTIN ASSOCIATION J. Biol. Chem., February 27, 2004; 279(9): 7999 - 8010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Mason, L. B. Kozell, and K. A. Neve Regulation of Dopamine D1 Receptor Trafficking by Protein Kinase A-Dependent Phosphorylation Mol. Pharmacol., April 1, 2002; 61(4): 806 - 816. [Abstract] [Full Text] [PDF] |
||||